TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers at Chalmers University of Technology analyzed nearly 3,000 blood proteins alongside genetic data and long-term health records to study how LDL, TRL and Lp(a) particles may relate to heart disease. Their findings point to shared inflammatory and blood-vessel processes for TRL and Lp(a), but the study did not test a treatment or establish a clinical protein test.
Researchers at Chalmers University of Technology have identified protein patterns linked to how three blood-fat particles may relate to heart disease, offering clues to risk that can remain even after LDL cholesterol is lowered. The study, published in the European Heart Journal, points to shared biological processes involving triglyceride-rich lipoproteins and Lp(a), but does not show that a new test or treatment can reduce risk.
The researchers examined LDL, or low-density lipoprotein; TRL, or triglyceride-rich lipoprotein; and Lp(a), or lipoprotein(a). All three can carry cholesterol into artery walls, but the study focused on protein patterns that could provide clues about how these particles affect the body beyond cholesterol accumulation.
The analysis combined measurements of almost 3,000 blood proteins with genetic data and long-term health records. The team found that TRL and Lp(a) shared many protein patterns, including proteins that may attract immune cells. The researchers said those patterns could be related to inflammation and changes in blood-vessel structure. LDL’s protein pattern was more closely associated with cholesterol build-up in artery walls.
The findings build on earlier work by the research group suggesting that counting harmful particles may predict future heart disease better than measuring cholesterol carried within them. The new report examines possible biological explanations for the risk linked to particles beyond LDL; it does not establish that the observed protein patterns cause disease.
Risk Beyond LDL Cholesterol
Lowering LDL cholesterol substantially reduces the risk of heart attacks, but some people develop coronary heart disease even after treatment brings LDL to a recommended level. This remaining risk is one reason researchers are examining other particles and the processes they may be associated with.
The apparent overlap between TRL and Lp(a) protein patterns may help researchers investigate whether some prevention strategies could address shared inflammatory or vascular processes. That is a research possibility, not a treatment recommendation: the study did not test whether acting on these patterns improves outcomes. LDL-lowering remains a cornerstone of prevention, according to the study’s lead investigator.
blood protein test kit for heart health
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Particle Study Worked
Coronary heart disease develops when fatty material accumulates in the blood vessels supplying the heart, and high blood cholesterol is a recognized risk factor. LDL is the most abundant of the particles examined. TRL carries triglycerides, while Lp(a) is another type of lipoprotein; all can deposit cholesterol in artery walls.
To look beyond those deposits, the team used proteomic analysis, which measures proteins in blood. Protein levels can vary with factors such as age, diet, stress and disease, so their patterns may offer clues about biological activity. The study, titled “Apolipoprotein B-containing lipoproteins: distinct roles in atherosclerosis revealed by plasma proteomic profiling,” was published in the European Heart Journal.
The World Health Organization says cardiovascular diseases cause nearly 17.9 million deaths each year worldwide, with heart attacks and strokes accounting for more than four out of five of those deaths. That burden makes it relevant to understand risk that may persist alongside established prevention, while keeping the limits of this study in view.
“For this study, we wanted to understand what happens beyond the accumulation of cholesterol in artery walls, whether different fat-carrying particles can damage the blood vessels differently and why the remaining risk of heart disease still occurs.”
— Jakub Morze, lead author and postdoctoral fellow at Chalmers University of Technology
As an affiliate, we earn on qualifying purchases.
What the Findings Do Not Show
The study identifies associations and protein patterns; it does not establish that those patterns cause heart disease. It also did not test a new treatment, show that targeting the identified processes lowers heart attacks, or establish a protein test for routine clinical use.
The source report does not provide enough detail here to assess the size of any added predictive benefit, how the patterns perform across different patient groups, or whether the findings will translate into clinical decisions. The researchers say further work is needed to determine whether measuring or targeting these processes can improve prevention.
As an affiliate, we earn on qualifying purchases.
Testing Paths to Prevention
The next research question, according to Wittenbecher, is whether measuring or targeting the identified biological processes can improve prevention alongside existing treatments. That would require further investigation beyond the protein-pattern analysis reported here, including evidence that any proposed approach can be used reliably and improve health outcomes.
For now, the findings add biological clues to ongoing research into heart-disease risk beyond LDL. They do not change the study’s stated position that lowering LDL remains a cornerstone of prevention, and they offer no basis for patients to alter treatment on their own.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the Chalmers study find?
It identified protein patterns associated with LDL, TRL and Lp(a). TRL and Lp(a) shared many patterns that researchers said may relate to inflammation and blood-vessel changes.
Does the study prove TRL or Lp(a) causes heart disease?
No. The report describes protein patterns and possible biological links. It does not establish that those patterns or particles caused disease.
Did the study test a new heart-disease treatment or blood test?
No. It did not test a treatment or establish a protein test for clinical use. The researchers said further work is needed to find out whether measuring or targeting the processes could improve prevention.
Does this mean lowering LDL is no longer important?
No. Study leader Clemens Wittenbecher said that lowering LDL cholesterol remains a cornerstone of prevention. The findings address possible sources of risk that may remain beyond LDL.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
